Glucagon-like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use Disorder
Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs), which were originally developed for managing type 2 diabetes by enhancing insulin secretion and reducing appetite, have emerged as promising candidates in alcohol use disorder (AUD). These medications offer a dual mechanism...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2025-06-01
|
| Серія: | Brain Sciences |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2076-3425/15/7/702 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|